FDA Approves Ycanth (cantharidin) Topical Solution for the Treatment of Molluscum Contagiosum

WEST CHESTER, PA–Jul 21, 2023 (GLOBE NEWSWIRE)– Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news